These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37669215)

  • 1. Bayesian joint models for multi-regional clinical trials.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2024 Jul; 25(3):852-866. PubMed ID: 37669215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian design of multi-regional clinical trials with time-to-event endpoints.
    Bean NW; Ibrahim JG; Psioda MA
    Biometrics; 2023 Dec; 79(4):3586-3598. PubMed ID: 36594642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian multiregional clinical trials using model averaging.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2023 Apr; 24(2):262-276. PubMed ID: 34296263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian modeling and prediction of accrual in multi-regional clinical trials.
    Deng Y; Zhang X; Long Q
    Stat Methods Med Res; 2017 Apr; 26(2):752-765. PubMed ID: 25367100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing consistency across all regions in a multi-regional clinical trial.
    Tsou HH; James Hung HM; Chen YM; Huang WS; Chang WJ; Hsiao CF
    Pharm Stat; 2012; 11(4):295-9. PubMed ID: 22504851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.
    Quan H; Li M; Shih WJ; Ouyang SP; Chen J; Zhang J; Zhao PL
    Stat Med; 2013 May; 32(10):1691-706. PubMed ID: 22855311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of estimand framework to the design and analysis of multi-regional clinical trials.
    Niu C; Liang L; Fu R; Zhong W; Wang WWB
    J Biopharm Stat; 2024 Jun; ():1-17. PubMed ID: 38840476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiparametric Bayesian inference on skew-normal joint modeling of multivariate longitudinal and survival data.
    Tang AM; Tang NS
    Stat Med; 2015 Feb; 34(5):824-43. PubMed ID: 25404574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graphical assessment of consistency in treatment effect among countries in multi-regional clinical trials.
    Chen J; Zheng H; Quan H; Li G; Gallo P; Ouyang SP; Binkowitz B; Ting N; Tanaka Y; Luo X; Ibia E;
    Clin Trials; 2013; 10(6):842-51. PubMed ID: 24013404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An empirical Bayes approach to evaluation of results for a specific region in multiregional clinical trials.
    Huang Y; Chang WJ; Hsiao CF
    Pharm Stat; 2013; 12(2):59-64. PubMed ID: 23319408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials.
    Liu JT; Tsou HH; Gordon Lan KK; Chen CT; Lai YH; Chang WJ; Tzeng CS; Hsiao CF
    Stat Med; 2016 Jun; 35(14):2301-14. PubMed ID: 26833851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian predictive model averaging approach to joint longitudinal-survival modeling: Application to an immuno-oncology clinical trial.
    Yao Z; Morita S; Nishida S; Sugiyama H
    Stat Med; 2023 Nov; 42(27):4990-5006. PubMed ID: 37705361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times.
    Liu J; Wick J; Jiang Y; Mayo M; Gajewski B
    Pharm Stat; 2020 Sep; 19(5):692-709. PubMed ID: 32319194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian hierarchical model for multiple repeated measures and survival data: an application to Parkinson's disease.
    Luo S; Wang J
    Stat Med; 2014 Oct; 33(24):4279-91. PubMed ID: 24935619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian joint modeling of multivariate longitudinal and survival outcomes using Gaussian copulas.
    Cho S; Psioda MA; Ibrahim JG
    Biostatistics; 2024 Oct; 25(4):962-977. PubMed ID: 38669589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Example-based illustrations of design, conduct, analysis and result interpretation of multi-regional clinical trials.
    Quan H; Mao X; Tanaka Y; Binkowitz B; Li G; Chen J; Zhang J; Zhao PL; Ouyang SP; Chang M
    Contemp Clin Trials; 2017 Jul; 58():13-22. PubMed ID: 28455233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian model for joint analysis of multivariate repeated measures and time to event data in crossover trials.
    Liu F; Li Q
    Stat Methods Med Res; 2016 Oct; 25(5):2180-2192. PubMed ID: 24448442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.
    Zhang J; Lin R; Chen X; Yan F
    Clin Trials; 2024 Jun; 21(3):308-321. PubMed ID: 38243401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian versus frequentist hypotheses testing in clinical trials with dichotomous and countable outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2010 Sep; 20(5):985-97. PubMed ID: 20721786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.